As part of a series of regular updates on developments in life sciences securities litigation (see Q3 2017 Quarterly Report), this report addresses recent activity in securities actions a...
Large-scale data breaches can give rise to a host of legal problems for the breached entity, ranging from consumer class action litigation to congressional inquiries and state attorneys g...
We previously highlighted the increased activity and some emerging patterns in securities litigation against life sciences companies during the first half of 2017. This report, the first...
In a recent column for the Daily Journal, Davis Polk partners Neal Potischman and Brian Weinstein discuss the flood of securities class action litigation in the life sciences sector and m...
We
previously outlined
the growing threat of securities class action lawsuits against life sciences companies and the importance of the United States Supreme Court’s decision in Omn...
Decision Yesterday and Two Denials of Certiorari Today Decline to Apply American Pipe Tolling to Statutes of Repose Under Both the ’33 Act and ’34 Act
On June 26, 2017, the United St...
Continuing its regulatory focus on cross-border audits on both the inspection and enforcement fronts, the PCAOB announced on March 29, 2017 that it had settled charges against two former ...
On December 5, 2016 the PCAOB announced that it had settled charges against Brazil-based Deloitte Touche Tohmatsu Auditores Independentes for a record $8 million civil penalty. PCAOB News...
Today, the Ninth Circuit issued an opinion in SEC v. Jensen. The court held that Rule 13a-14 of the Securities Exchange Act confirms that the SEC has a cause of action against CEOs and C...
On November 4, 2010, the Securities and Exchange Commission (“SEC”) and U.S. Department of Justice (“DOJ”) announced much-anticipated resolutions of Foreign Corrupt Practices Act ...
